In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

That Ozempic (or Wegovy, the name by which the weight-loss version of the drug semaglutide is marketed) should have proliferated in an industry that has always venerated thinness will hardly come as a ...

The global weight management market is poised for significant growth over the next decade, driven by increasing awareness of ...

The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam.Most Read from ...

Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

The chair of Vale Base Metals has said mining group Vale is eyeing a possible public listing for the business at the end of 2026, which he said could be worth $40bn.

Weight loss drugs have become popular due to social media and celebrities using them to shed excess pounds quickly. Although ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

But Lilly isn't alone in the market, and in the coming years, this space could become more crowded. Today, Lilly competes ...

On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, ...

The injection has previously been used to treat diabetes , but has faced criticism in recent months after a string of celebs ...

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had ...